VIH/sida et tuberculose
VIH/sida et tuberculose : dépistage, traitements antirétroviraux et antituberculeux, co-infection, prévention et prise en charge.
Critères d'inclusion : Documents publiés sur SPHAERO dont le titre ou les mots-clés contiennent l'un des termes suivants (mot entier, avec ses variantes) : VIH, HIV, sida, antirétroviral, antiretroviral, tuberculose, tuberculosis, PTME, PMTCT. Composition recalculée chaque nuit.
Responsable : Équipe éditoriale SPHAERO. Composition mise à jour le 22/11/2026.
Article scientifique
Impact of antiretroviral treatment on height evolution of HIV infected children
BACKGROUND: Antiretroviral treatment (ART) has been shown to have a beneficial effect on the weight evolution but its effect on …
Article scientifique
Addressing challenges in tuberculosis adherence via performance-based payments for integrated case management: protocol for a cluster randomized controlled trial in Georgia
BACKGROUND: Tuberculosis is one of the greatest global health concerns and disease management is challenging particularly in low- and middle-income …
Article scientifique
Estimating the annual risk of infection with Mycobacterium tuberculosis among adolescents in Western Kenya in preparation for TB vaccine trials
BACKGROUND: Adolescents are a prime target group for tuberculosis (TB) vaccine trials that include prevention of infection (POI). The BCG …
Article scientifique
Outsiders, insiders, and intermediaries: village health teams’ negotiation of roles to provide high quality sexual, reproductive and HIV care in Nakaseke, Uganda
BACKGROUND: Community health workers, known as Village Health Teams (VHTs) in Uganda, play a central role in increasing access to …
Article scientifique
Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP)
INTRODUCTION: Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) …
Article scientifique
Childhood tuberculosis and treatment outcomes in Accra: a retrospective analysis
BACKGROUND: Tuberculosis (TB) is a leading cause of death in children and adults. Unlike for adults, there is paucity of …
Article scientifique
Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation
BACKGROUND: Improving access to paediatric HIV treatment requires large-scale antiretroviral treatment programmes and medication adapted to infants and children's needs. …
Article scientifique
Social barriers in accessing care by clients who returned to HIV care after transient loss to follow-up
BACKGROUND: People living with HIV (PLHIV) constantly need to address social issues such as the cost of accessing care, stigma, …
Article scientifique
Integrated Care Delivery for HIV Prevention and Treatment in Adolescent Girls and Young Women in Zambia: Protocol for a Cluster-Randomized Controlled Trial
BACKGROUND: Among countries in sub-Saharan Africa, Zambia has one of the highest incidences of HIV. Adolescent girls and young women …
Article scientifique
Personal carbon monoxide exposure, respiratory symptoms, and the potentially modifying roles of sex and HIV infection in rural Uganda: a cohort study
BACKGROUND: Most of the global burden of pollution-related morbidity and mortality is believed to occur in resource-limited settings, where HIV …
Article scientifique
Analysis of the TCR Repertoire in HIV-Exposed but Uninfected Infants
Maternal human immunodeficiency virus (HIV) infection has been shown to leave profound and lasting impacts on the HIV-exposed uninfected (HEU) …
Article scientifique
Psychosocial correlates of self-reported HIV among youth in the slums of Kampala
Human immunodeficiency virus (HIV) rates are high in Uganda (6.7%), and rates are especially high among at-risk groups such as …
Article scientifique
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030
BACKGROUND: Over 90% of Human Immunodeficiency Virus (HIV) infected individuals will be on treatment by 2020 under UNAIDS 90-90-90 global …
Article scientifique
Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco
Increased prevalence of latent tuberculosis infection (LTBI) has been observed among high-risk populations such as healthcare workers (HCWs). The results …
Article scientifique
Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania
BACKGROUND: Despite an increased uptake of option B+ treatment among HIV- positive pregnant and breastfeeding women, retaining these women in …
Article scientifique
Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers
Cytotoxic CD4+ T cells play a prominent role in chronic viral infection. CD4+ CTL clones specific for HIV-1 Nef and …
Article scientifique
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
We compared the ability of commercial and non-commercial, phenotypic and genotypic rapid drug susceptibility tests (DSTs) to detect rifampicin resistance …
Article scientifique
Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study
BACKGROUND: Tuberculosis (TB) remains a major health problem worldwide and in Ethiopia. This study aimed to investigate the spatial distributions …
Article scientifique
False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients
BACKGROUND: A small proportion of false rifampicin resistant results have previously been reported using GeneXpert MTB/RIF version G4 on sputum …
Article scientifique
Performance characteristics of a modified HIV-1 drug resistance genotyping method for use in resource-limited settings
Background: HIV-1 drug resistance (HIVDR) assays are critical components of HIV clinical management programs in the face of emerging drug …